Biocon Limited
BIOCON
株式のランク
#3365
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
株価
$3.77
時価総額
$5.15B
変化（1日）
-1.94%
変化（1年）
-6.92%
国
IN
取引 Biocon Limited (BIOCON)
カテゴリー
Healthcare
Biocon Limited（BIOCON）のEPS
June 2026 時点のEPS TTM: $0.04
Biocon Limitedの最新の財務報告と株価によると、同社の現在のEPS（TTM）は$0.04です。2024年末には、EPSは$0.10で、2023年のEPS$0.05と増加でした。
Biocon LimitedのEPS履歴（2004から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $0.04 | -62.50% |
| 2025 | $0.10 | -3.51% |
| 2024 | $0.10 | 117.16% |
| 2023 | $0.05 | -34.17% |
| 2022 | $0.07 | -15.85% |
| 2021 | $0.09 | 1.55% |
| 2020 | $0.08 | -23.87% |
| 2019 | $0.11 | 127.22% |
| 2018 | $0.05 | -39.53% |
| 2017 | $0.08 | 13.76% |
| 2016 | $0.07 | 6.33% |
| 2015 | $0.07 | 12.95% |
| 2014 | $0.06 | -26.35% |
| 2013 | $0.08 | 40.32% |
| 2012 | $0.06 | -19.09% |
| 2011 | $0.07 | 25.58% |
| 2010 | $0.06 | 249.38% |
| 2009 | $0.02 | -84.00% |
| 2008 | $0.10 | 142.13% |
| 2007 | $0.04 | 21.11% |
| 2006 | $0.03 | -14.32% |
| 2005 | $0.04 | 27.16% |
| 2004 | $0.03 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| $17.32 | 46,086.67% |
US
|
|
| $-7.98 | -21,380.00% |
US
|
|
| $-5.29 | -14,206.67% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 73,873.33% |
NL
|
